|
Volume 271,
Number 10,
Issue of March 8, 1996 pp. 5824-5831
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Type
II Human Complement C2 Deficiency
ALLELE-SPECIFIC AMINO ACID SUBSTITUTIONS (Ser
Phe; Gly Arg) CAUSE IMPAIRED C2 SECRETION
(Received for publication, September 1, 1995; and in revised form, November 6,
1995)
Rick A.
Wetsel
,
Judit
Kulics,
Marja-Liisa
Lokki ,
Photini
Kiepiela,
Hideto
Akama ,
Charles A. C.
Johnson,
Peter
Densen
,
Harvey R.
Colten
Type II complement protein C2 deficiency is characterized by a
selective block in C2 secretion. The Type II C2 null allele (C2Q0) is
linked to two major histocompatibility haplotypes (MHC) that differ
from the MHC of the more common Type I C2 deficiency. To determine the
molecular basis of Type II deficiency the two Type II C2Q0 genes were
isolated and transfected separately into L-cells. Subsequent molecular
biology, biosynthetic, and immunofluorescence studies demonstrated that
C2 secretion is impaired in Type II C2 deficiency because of different
missense mutations at highly conserved residues in each of the C2Q0
alleles. One is in exon 5 (nucleotide C T;
Ser Phe) of the C2Q0 gene linked to the MHC
haplotype A11,B35,DRw1,BFS, C4A0B1. The other is in exon 11 (G A; Gly Arg) of the C2Q0 gene linked
to the MHC haplotype A2,B5, DRw4,BFS,C4A3B1. Each mutant C2 gene
product is retained early in the secretory pathway. These mutants
provide models for elucidating the C2 secretory pathway.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I Richard
The genetic and molecular bases of monogenic disorders affecting proteolytic systems
J. Med. Genet.,
July 1, 2005;
42(7):
529 - 539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Z. Schmidt, N. L. Fowler, T. Hidvegi, D. H. Perlmutter, and H. R. Colten
Disruption of Disulfide Bonds Is Responsible for Impaired Secretion in Human Complement Factor H Deficiency
J. Biol. Chem.,
April 23, 1999;
274(17):
11782 - 11788.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-B. Zhu, T. P. Atkinson, and J. E. Volanakis
A Novel Type II Complement C2 Deficiency Allele in an African-American Family
J. Immunol.,
July 15, 1998;
161(2):
578 - 584.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Matsumoto, W. Fukuda, A. Circolo, J. Goellner, J. Strauss-Schoenberger, X. Wang, S. Fujita, T. Hidvegi, D. D. Chaplin, and H. R. Colten
Abrogation of the alternative complement pathway by targeted deletion of murine factor B
PNAS,
August 5, 1997;
94(16):
8720 - 8725.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|